Skip to main content

Versant Diagnostics Announces the Acquisition of Associate Pathologists of Joliet, Ltd. to Advance Access to Pathology in the Midwest

Grapevine, Texas, May 14, 2024 (GLOBE NEWSWIRE) — Versant Diagnostics, an independent physician services company, today announced the acquisition of Associate Pathologists of Joliet, Ltd., a multi-specialty pathology practice based in Joliet, Ill. This acquisition expands Versant Diagnostics’ nationwide network of pathology practices and increases its presence in the Midwest. Renowned pathologist James Urban, M.D., Ph.D. is the President of the group in the greater Chicago area.

“Dr. Urban is a respected physician who has built an exceptional practice that regularly creates ways to improve patient care,” says Jim Billington, Chief Executive Officer at Versant Diagnostics. “This collaboration with one of the Midwest’s premiere pathology providers will expand physician and patient access to our growing network of leading specialists.”

“We are excited about the opportunity to join an expanding group of high-quality pathologists at Versant Diagnostics,” says Dr. Urban, President of Associate Pathologists of Joliet, Ltd. “This partnership will allow us to provide additional services for our patients, and to collaborate with other Versant specialists nationwide. Pathology is changing rapidly, and the team at Versant is committed to implementing the proper resources to stay ahead of the curve.”

Versant Diagnostics provides the necessary resources, infrastructure, and technology to their multi-specialty pathologists, with the mission to improve patient outcomes, elevate care, and save lives. Versant Diagnostics’ sub-specialty experts cover the areas of Breast Pathology, Clinical Pathology, Dermatopathology, Gastrointestinal Pathology, General Surgical Pathology, Hematopathology, Renal Pathology, Urology Pathology, and Women’s Health/Gynecological Pathology.

Versant Diagnostics is rapidly advancing digital pathology in anatomic pathology labs and specialty clinics and has an aggressive growth strategy into more markets and sub-specialties. Backing for the strategy is made possible by Iron Path Capital.

###

About Versant Diagnostics

Founded in 2021 by physician Ven Aduana, M.D. and operating executives Jim Billington and Brian Carr, Versant Diagnostics is focused on anatomic pathology and the digital transformation of the industry. By combining technological advancements in healthcare with a skilled set of subspecialty pathologists, Versant Diagnostics provides superior service for hospitals and physician practices. Learn more at www.versantdx.com.

CONTACT: Renee Cossman
renee@cossmanpr.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.